Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Bosutinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Niclosamide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 9 0
Clofazimine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 4 0
Z-FA-FMK Potential treatment - pre-clinical evidence Experimental Antiviral Jan/24/2021 2 0
Lactoferrin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/23/2021 3 0
Thioguanine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 1 1
Amiodarone  Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/28/2020 5 1
Excel (.xslx) CSV (.csv)